oral semaglutide obesity In the OASIS 4 phase 3 trial, once-daily at a dose of 25 mg resulted in a greater mean reduction in body weight than placebo in participants with overweight or VisualAbstract:Oral semaglutide effectively reduces bodyweight

The potential side effects of GLP-1 drugs are no fun: nausea, vomiting, fatigue, diarrhea, constipation

Tauchi M, Fuchs TA, Kellenberger AJ, Woodward DF, Paus R, Lutjen-Drecoll E (2010) Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost

If you had undiagnosed GERD before starting treatment, Zepbound may make existing disease symptomatic

Good sleep

The safety has not been well studied

The dosing miscommunications, shipping delays, and customer service gaps documented in negative reviews represent real problems that affect a meaningful minority of customers